Wei‐Ting Hwang

27.0k citations
272 papers · 14.1k · 6 hit papers · h-index 55

Impact in

  • Oncology top 0.2%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
    • Breast Cancer Treatment Studies

Papers in

    • CAR-T cell therapy research 37
    • Cancer Immunotherapy and Biomarkers 17
    • Breast Cancer Treatment Studies 25

Wei‐Ting Hwang

262 papers receiving 13.7k citations

Wei‐Ting Hwang's Hit Papers

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma 2015 · 437 citations
4370+7+14Years since publication4008001.2k

Peers

Wei‐Ting Hwang
Comparison fields: 5 of 183
  • Oncology 4.8k
  • Cancer Research 1.5k
  • Virology 472
  • Immunology 1.5k
  • Research and Theory 62
Replace Alfred Rademaker with:
Alfred Rademaker United States
Peng Li China
David A. Davis United States
David Goldstein Australia
Thomas M. Habermann United States
Fiona Campbell United Kingdom
Sohee Park South Korea
Carol Stocking Germany
Francesca Moretti Italy
Xiaohong Wang China
Wei‐Ting Hwang relative to Alfred Rademaker United States Alfred Rademaker's profile →
Citations per field
00.5×10.3×
Alfred Rademaker · 1×
Citations per year

Countries citing papers authored by Wei‐Ting Hwang

Since Specialization
Citations

This map shows the geographic impact of Wei‐Ting Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ting Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ting Hwang more than expected).

Fields of papers citing papers by Wei‐Ting Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ting Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ting Hwang. The network helps show where Wei‐Ting Hwang may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei‐Ting Hwang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei‐Ting Hwang Line = papers co-authored together Wei‐Ting Hwang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
Hit paper breakdown →
20151329
2
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Hit paper breakdown →
2014979
3
The Working Hours Of Hospital Staff Nurses And Patient Safety
Hit paper breakdown →
2004725
4
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
Hit paper breakdown →
2012503
5
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Hit paper breakdown →
2011499
6
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Hit paper breakdown →
2015437
7 2006321
8 2007303
9 2006284
10 2004264
11 2008245
12 2013244
13 2005231
14 2008221
15 2007205
16 2017204
17 2016200
18 2007179
19 2005165
20 2009158

About Wei‐Ting Hwang

Wei‐Ting Hwang is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 272 papers that have together received 14.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (37 papers), Breast Cancer Treatment Studies (25 papers), Bladder and Urothelial Cancer Treatments (20 papers), Cancer Immunotherapy and Biomarkers (17 papers), Childhood Cancer Survivors' Quality of Life (13 papers), Lung Cancer Treatments and Mutations (12 papers), Urinary and Genital Oncology Studies (11 papers) and Prostate Cancer Diagnosis and Treatment (11 papers). The work is most often cited by research in Oncology (4.8k citations), Cancer Research (1.5k citations), Virology (472 citations), Immunology (1.5k citations) and Research and Theory (62 citations). Wei‐Ting Hwang has collaborated with scholars based in United States, Egypt and Netherlands. Frequent co-authors include Ann E. Rogers, Linda D. Scott, Lawrence J. Solin, Carl H. June, Eleanor Harris, Bruce L. Levine, David F. Dinges, Anne E. Kazak, Curtiland Deville and Linda H. Aiken. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Blood, Cancer and Journal of Pediatric Psychology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact